Molecular editing method could speed drug discovery
Scientists unveiled a reaction that swaps key carbon groups in complex compounds, offering a faster route to test new medicine candidates.
Search fresh public links, source activity, and ready-to-use post angles for Drug Discovery.
Fresh curated links around drug discovery are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Scientists unveiled a reaction that swaps key carbon groups in complex compounds, offering a faster route to test new medicine candidates.
Despite remarkable progress in medical science, the prognosis for most patients diagnosed with advanced-stage cancers remains bleak. The challenge lies not only in the complexity o...
ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...
Advances in end-to-end multiomics platforms and the underlying scientific knowledge now enable faster and more precise biomarker discovery, mechanistic insight generation, and ther...
David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...
ZoBio maintains that unlike transactional DEL screening approaches that focus solely on hit generation, its platform is designed to deliver biologically relevant, structurally char...
Researchers used two AI systems, Robin and Co-Scientist, to collapse the timeline from idea to drug candidate. The post AI Lab Partners Are Rewiring the Hunt for New Drugs appeared...
As researchers work to develop new cancer treatments, one of the biggest challenges is identifying promising drug candidates quickly and efficiently. Now, researchers at Purdue Uni...
New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new "receptor diversion" microscopy-based screening system for targeting receptors long considered diffi...
Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of research starts. The post The hidden innovation system be...
Insider Brief It’s one thing to design a pharmaceutical drug. It’s another to know if and why it actually works. Not on paper or in a computer model. But inside the chaotic world o...
In early discovery, researchers use high-throughput screening (HTS) to identify active compounds in a biologically relevant context. During lead characterization and validation, th...
AI will continue changing how small molecules are discovered, but the candidates that generate the most interest in silico still have to succeed under real development conditions....
A new method screens large libraries of synthetic cyclic peptides to identify compounds that can enter cells for therapeutic effect, opening avenues for a modality that combines th...
Macrocycles, de novo antibodies, and mRNA therapies are expanding the drug discovery toolbox for unmet patient needs. The post Novel Therapeutic Modalities Target the Undruggable a...
Deep learning unveils how drugs affect the dynamics of key structures within the cell. A new study maps condensate morphology to functional outcomes and sheds light on markers of h...
Next-generation MS platforms are transforming drug discovery by revealing complex biology earlier, faster, and at unprecedented depth. The post Mass Spectrometry’s Discovery Revolu...
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in know...
Formerly known as Verge Genomics, the new Verge Labs will help pharma and biotech partners match potential brain drugs to patients who best benefit from them.
Ampyrone—an NSAID-related compound—has emerged as a promising way to enhance melanin production in human skin, according to a preclinical study led by Weill Cornell Medicine and Na...
The partnership’s first phase will see a review of the current medicines landscape conducted to identify opportunities for innovation. This information will be used to find systemi...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.